News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Aquilo Capital Management, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
SC 13G/A
| Aquilo Capital Management, LLC reports a 7.5% stake in PIERIS PHARMACEUTICALS, INC. |
| 02/14/2023 |
SC 13G/A
| Aquilo Capital Management, LLC reports a 0% stake in SPERO THERAPEUTICS, INC. |
| 02/14/2023 |
SC 13G/A
| Aquilo Capital Management, LLC reports a 0% stake in Magenta Therapeutics, Inc. |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/03/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/26/2022 |
4
| Aquilo Capital Management, LLC (10% Owner) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Sold 1,335,512 shares
@ $2.2503, valued at
$3M
Sold 566,284 shares
@ $2.2503, valued at
$1.3M
|
|
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/28/2022 |
4
| Aquilo Capital Management, LLC (10% Owner) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Bought 39,727 shares
@ $5.235, valued at
$208k
|
|
| 03/31/2022 |
4
| Aquilo Capital Management, LLC (10% Owner) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Bought 33,115 shares
@ $8.7884, valued at
$291k
Bought 16,885 shares
@ $8.7884, valued at
$148.4k
|
|
| 03/16/2022 |
4
| Aquilo Capital Management, LLC (10% Owner) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Bought 15,702 shares
@ $7.626, valued at
$119.7k
Bought 8,006 shares
@ $7.626, valued at
$61.1k
|
|
| 03/08/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Aquilo Capital Management, LLC (10% Owner) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Bought 14,828 shares
@ $9.2419, valued at
$137k
|
|
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
SC 13G/A
| Aquilo Capital Management, LLC reports a 15.4% stake in SPERO THERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G/A
| Aquilo Capital Management, LLC reports a 5.9% stake in PIERIS PHARMACEUTICALS, INC. |
| 02/14/2022 |
SC 13G
| Aquilo Capital Management, LLC reports a 5.4% stake in Magenta Therapeutics, Inc. |
| 02/01/2022 |
4
| Aquilo Capital Management, LLC (10% Owner) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Bought 125,000 shares
@ $11.5861, valued at
$1.4M
|
|
| 01/26/2022 |
4
| Aquilo Capital Management, LLC (10% Owner) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Bought 1,599 shares
@ $10.8931, valued at
$17.4k
|
|
| 01/20/2022 |
4
| Aquilo Capital Management, LLC (10% Owner) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Bought 48,488 shares
@ $12.4147, valued at
$602k
|
|
| 01/12/2022 |
4
| Aquilo Capital Management, LLC (10% Owner) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Bought 8,867 shares
@ $12.9253, valued at
$114.6k
|
|
| 01/03/2022 |
4
| Aquilo Capital Management, LLC (10% Owner) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Bought 75,493 shares
@ $14.6406, valued at
$1.1M
Bought 50,000 shares
@ $15.7722, valued at
$788.6k
Bought 125,000 shares
@ $15.7522, valued at
$2M
|
|
| 11/02/2021 |
4
| Aquilo Capital Management, LLC (10% Owner) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Bought 150,000 shares
@ $17.5345, valued at
$2.6M
|
|
| 10/04/2021 |
4
| Aquilo Capital Management, LLC (10% Owner) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Bought 134,543 shares
@ $18.6496, valued at
$2.5M
|
|
| 09/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
|
|
|